Filing Details

Accession Number:
0000950170-24-140393
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-26 16:02:31
Reporting Period:
2024-12-23
Accepted Time:
2024-12-26 16:02:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1971543 Mural Oncology Plc MURA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1693805 Maiken Keson-Brookes C/O Mural Oncology Plc
10 Earlsfort Terrace
Dublin 2 L2 D02 T380
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2024-12-23 2,555 $3.27 41,295 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares automatically sold by the Reporting Person pursuant to a Rule 10b5-1 trading arrangement that was entered into by the Reporting Person on September 20, 2024.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.24 to $3.33. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes 38,705 unvested restricted stock units.